Owing to its role in controlling cytokine and chemokine production during inflammatory processes, Map3k8 has been identified as a potentially interesting target for the treatment of various diseases, including autoimmune and liver diseases and diverse types of cancer37–41. This evidence concerns the gene MAP3K8 and liver disorder.